146 related articles for article (PubMed ID: 7607965)
21. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate.
Reddick WE; Glass JO; Helton KJ; Langston JW; Xiong X; Wu S; Pui CH
AJNR Am J Neuroradiol; 2005 May; 26(5):1263-9. PubMed ID: 15891195
[TBL] [Abstract][Full Text] [Related]
22. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
[TBL] [Abstract][Full Text] [Related]
23. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
[TBL] [Abstract][Full Text] [Related]
24. Computed tomography brain scans in children with acute lymphocytic leukemia receiving methotrexate alone as central nervous system prophylaxis.
Ochs JJ; Berger P; Brecher ML; Sinks LF; Kinkel W; Freeman AI
Cancer; 1980 May; 45(9):2274-8. PubMed ID: 6929724
[TBL] [Abstract][Full Text] [Related]
25. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
[TBL] [Abstract][Full Text] [Related]
26. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
Tubergen DG; Gilchrist GS; O'Brien RT; Coccia PF; Sather HN; Waskerwitz MJ; Hammond GD
J Clin Oncol; 1993 Mar; 11(3):520-6. PubMed ID: 8445427
[TBL] [Abstract][Full Text] [Related]
27. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
Razzouk BI; Rose SR; Hongeng S; Wallace D; Smeltzer MP; Zacher M; Pui CH; Hudson MM
J Clin Oncol; 2007 Apr; 25(10):1183-9. PubMed ID: 17401007
[TBL] [Abstract][Full Text] [Related]
28. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate.
Asato R; Akiyama Y; Ito M; Kubota M; Okumura R; Miki Y; Konishi J; Mikawa H
Cancer; 1992 Oct; 70(7):1997-2004. PubMed ID: 1525778
[TBL] [Abstract][Full Text] [Related]
29. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of intrathecal methotrexate with and without cranial radiotherapy in preventing central nervous system relapses in acute lymphocytic leukemia.
Choudhry VP; Krishnamurthy L; Rath GK; Arya LS; Pati H; Saraya AK
Indian Pediatr; 1992 Jul; 29(7):843-9. PubMed ID: 1428132
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
32. CNS prophylaxis of childhood leukemia: what are the long-term neurological, neuropsychological, and behavioral effects?
Stehbens JA; Kaleita TA; Noll RB; MacLean WE; O'Brien RT; Waskerwitz MJ; Hammond GD
Neuropsychol Rev; 1991 Jun; 2(2):147-77. PubMed ID: 1844707
[TBL] [Abstract][Full Text] [Related]
33. Prophylaxis and treatment of neoplastic meningeosis in childhood acute lymphoblastic leukemia.
Schrappe M; Reiter A; Riehm H
J Neurooncol; 1998; 38(2-3):159-65. PubMed ID: 9696367
[TBL] [Abstract][Full Text] [Related]
34. Toxicity following concurrent intrathecal and moderate-dose intravenous methotrexate.
Blatt J; Howrie DL; Wollman MR; Phebus C; Mirro J
Leukemia; 1993 Nov; 7(11):1734-7. PubMed ID: 8231243
[TBL] [Abstract][Full Text] [Related]
35. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
Kähkönen M; Metsähonkala L; Minn H; Utriainen T; Korhonen T; Norvasuo-Heilä MK; Harila-Saari A; Aärimaa T; Suhonen-Polvi H; Ruotsalainen U; Solin O; Salmi TT
Cancer; 2000 Feb; 88(3):693-700. PubMed ID: 10649265
[TBL] [Abstract][Full Text] [Related]
36. Brain perfusion after treatment of childhood acute lymphoblastic leukemia.
Harila-Saari AH; Ahonen AK; Vainionpää LK; Pääkkö EL; Pyhtinen J; Himanen AS; Torniainen PJ; Lanning BM
J Nucl Med; 1997 Jan; 38(1):82-8. PubMed ID: 8998157
[TBL] [Abstract][Full Text] [Related]
37. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
[TBL] [Abstract][Full Text] [Related]
38. Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.
Raghavendra S; Nair MD; Chemmanam T; Krishnamoorthy T; Radhakrishnan VV; Kuruvilla A
Eur J Neurol; 2007 Mar; 14(3):309-14. PubMed ID: 17355553
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of prophylactic additional cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL.
Fukano R; Nishimura M; Ito N; Nakashima K; Kodama Y; Okamura J; Inagaki J
Pediatr Transplant; 2014 Aug; 18(5):518-23. PubMed ID: 24815062
[TBL] [Abstract][Full Text] [Related]
40. Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P.
Nathan PC; Whitcomb T; Wolters PL; Steinberg SM; Balis FM; Brouwers P; Hunsberger S; Feusner J; Sather H; Miser J; Odom LF; Poplack D; Reaman G; Bleyer WA
Leuk Lymphoma; 2006 Dec; 47(12):2488-504. PubMed ID: 17169794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]